Month: November 2016

The Dow suffered a week of losses following rising uncertainty over the outcome of the U.S. Presidential election. The FBI said it was probing new personal emails of Hillary Clinton. […]

The last week was a crucial one as we had results from almost all big names in the video game industry. Plus, leading video game retailer, GameStop Corp GME slashed its third quarter and full year 2016 outlook citing weak sales of new games. Recap of the Developments 1. […]

Arena Pharmaceuticals, Inc. ARNA is scheduled to report third-quarter 2016 results on Nov 7, after the market closes. […]

PG&E Corporation ’s PCG adjusted operating earnings per share of 94 cents in the third quarter of 2016 lagged the Zacks Consensus Estimate of $1.10 per share by 14.5%. Earnings were, however, up 11.9% from 84 cents reported in the year-ago quarter. […]

Kite Pharma, Inc. KITE will be reporting third-quarter 2016 earnings on Nov 9, before market open. Last quarter, the company delivered a negative earnings surprise of 2.34%. […]

The St. Joe Company JOE reported third-quarter 2016 net income per share of 4 cents, which surpassed the Zacks Consensus Estimate of 2 cents and came ahead of the year-ago quarter tally of 3 cents. Lower expenses contributed to this beat. […]

Agios Pharmaceuticals, Inc. AGIO posted third-quarter 2016 loss of $1.63 per share, wider than the Zacks Consensus Estimate of a loss of $1.51 and the year-ago loss of $1.07. […]

Ameren Corporation AEE posted third-quarter 2016 earnings from continuing operations of $1.52 per share, beating the Zacks Consensus Estimate of $1.38 by 10.1%. Earnings also increased 7.8% year over year. […]

Exelixis, Inc. EXEL posted third-quarter 2016 loss of 4 cents, narrower than both the Zacks Consensus Estimate of a loss of 13 cents and the year-ago loss of 21 cents. Higher revenues and lower R&D costs led to the narrower loss in the quarter. […]

Orexigen Therapeutics, Inc. OREX reported a loss of $1.01 per share in the third quarter of 2016, narrower than the Zacks Consensus Estimate of $2.13 but wider than the year-ago loss of 86 cents. FindTheCompany | Graphiq Quarterly revenues came in at approximately $7 million, down from to $10 million in the year-ago quarter, which included an anniversary milestone earned from Takeda Pharmaceutical Company Limited TKPYY […]

Ubiquiti Networks, Inc. UBNT maintained its winning streak with another striking beat, as its first-quarter fiscal 2017 reported earnings of 86 cents a share crushed the Zacks Consensus Estimate of 65 cents by 32.3%.The earnings surprise marks Ubiquiti’s sixth consecutive beat. […]

Humana Inc. ’s HUM third-quarter 2016 operating earnings per share of $3.18 beat the Zacks Consensus Estimate of $3.06 roughly by 4%. […]

Regeneron Pharmaceuticals, Inc. REGN reported third-quarter 2016 earnings (including the impact of share-based compensation expenses and tax adjustments) of $2.41 per share, above the Zacks Consensus Estimate of $2.27. […]